Mixed Monoclonal Antibody Cocktail for Cancer Immunotherapy
This product is a blend of multiple monoclonal antibodies (e.g., pembrolizumab and nivolumab derivatives) designed for immunotherapy treatment of solid tumors. It falls under HTS 3002.14.00.90 as mixed immunological products not in measured doses or retail packaging, per chapter notes defining immunological products as peptides/proteins regulating immunological processes.
Import Duty Rates by Country of Origin
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If not mixed, supplied as individual monoclonal antibodies
Unmixed immunological products like single MABs classify under 3002.13, while mixtures move to 3002.14 per chapter note 3(a).
If put up in measured doses for retail sale
Retail-packed versions shift to 3002.90 as they no longer qualify as 'not put up in measured doses' under 3002.14.
If classified primarily as hormones rather than immunological regulators
Certain biotech products based on heading 2937 hormones exclude from chapter 30 immunological definitions.
Not sure which classification is right?
The Tariff Assistant works through the GRI rules on your specific product to reach the right HTS code — and can price the duty on it in the same conversation.
Import Tips & Compliance
• Obtain FDA biologics license application (BLA) approval prior to import; provide lot-specific certificates of analysis
• Declare as mixed immunological product; avoid retail packaging to stay in 3002.14, include biotech process details
Related Products under HTS 3002.14.00.90
Antibody Fragment Conjugate Mixture for Targeted Therapy
Blend of antibody fragments and conjugates for precise immune targeting in autoimmune diseases. HTS 3002.14.00.90 for mixed, non-retail immunological products including antibody conjugates per chapter notes.
Blended Interferon-Alpha and Interleukin-2 Therapy
A mixed preparation of recombinant interferon-alpha and interleukin-2 for treating viral infections and boosting immune response in immunotherapy. Classified in HTS 3002.14.00.90 as mixed immunological products (interferons and interleukins per chapter notes) not for retail sale.
Cytokine Mixture for Immunomodulation (TNF and Growth Factors)
Bulk mixed solution of tumor necrosis factors (TNF) and growth factors for regulating immune responses in clinical settings. HTS 3002.14.00.90 applies to these mixed immunological products (TNF/GF per notes) not in retail forms.
Hematopoietin and Colony Stimulating Factor Blend
Mixed hematopoietins and colony stimulating factors (CSF) for bone marrow stimulation in chemotherapy patients. Fits HTS 3002.14.00.90 as mixed biotech immunological products for bulk clinical use.